![PDF] Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval | Semantic Scholar PDF] Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4b7abe3c7dbec24e5d9af5e00b9bc95268b53603/4-Table1-1.png)
PDF] Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval | Semantic Scholar
![Frontiers | Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer Frontiers | Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer](https://www.frontiersin.org/files/MyHome%20Article%20Library/760655/760655_Thumb_400.jpg)
Frontiers | Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
![Figure 1 from Classical taxane versus the new generation , nab-paclitaxel chemotherapy in the treatment of breast cancer | Semantic Scholar Figure 1 from Classical taxane versus the new generation , nab-paclitaxel chemotherapy in the treatment of breast cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a74471315040f216540df9e24f01b6ac996bcfcc/3-Figure2-1.png)
Figure 1 from Classical taxane versus the new generation , nab-paclitaxel chemotherapy in the treatment of breast cancer | Semantic Scholar
![Chemical structure of Paclitaxel and the albumin conjugated variant... | Download Scientific Diagram Chemical structure of Paclitaxel and the albumin conjugated variant... | Download Scientific Diagram](https://www.researchgate.net/publication/353277452/figure/fig2/AS:1046004384161801@1626398287917/Chemical-structure-of-Paclitaxel-and-the-albumin-conjugated-variant-Nab-Paclitaxel.png)
Chemical structure of Paclitaxel and the albumin conjugated variant... | Download Scientific Diagram
![Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer? | Journal of Clinical Oncology Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer? | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.19.00877/asset/images/large/jco.19.00877t2.jpeg)
Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer? | Journal of Clinical Oncology
A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo | PLOS ONE
![NEJM on X: "#VisualAbstract: Aezolizumab + nab-paclitaxel as first-line therapy for patients with advanced or metastatic triple-negative #breastcancer significantly prolonged progression-free survival, particularly among those with PD-L1–positive ... NEJM on X: "#VisualAbstract: Aezolizumab + nab-paclitaxel as first-line therapy for patients with advanced or metastatic triple-negative #breastcancer significantly prolonged progression-free survival, particularly among those with PD-L1–positive ...](https://pbs.twimg.com/media/DtMiuSQW0AA2KQB.jpg)
NEJM on X: "#VisualAbstract: Aezolizumab + nab-paclitaxel as first-line therapy for patients with advanced or metastatic triple-negative #breastcancer significantly prolonged progression-free survival, particularly among those with PD-L1–positive ...
![Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis | BMC Cancer | Full Text Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-021-07831-7/MediaObjects/12885_2021_7831_Fig2_HTML.png)
Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis | BMC Cancer | Full Text
![NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69–GeparSepto | Journal of Clinical Oncology NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69–GeparSepto | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.18.01842/asset/images/large/jco.18.01842app1.jpeg)
NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69–GeparSepto | Journal of Clinical Oncology
![Biomedicines | Free Full-Text | Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety Biomedicines | Free Full-Text | Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety](https://pub.mdpi-res.com/biomedicines/biomedicines-11-02000/article_deploy/html/images/biomedicines-11-02000-g002.png?1689406835)
Biomedicines | Free Full-Text | Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
![Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model | Cell Death Discovery Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model | Cell Death Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41420-023-01397-y/MediaObjects/41420_2023_1397_Fig1_HTML.png)
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model | Cell Death Discovery
![Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer | British Journal of Cancer Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2016.215/MediaObjects/41416_2016_Article_BFbjc2016215_Fig1_HTML.jpg)
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer | British Journal of Cancer
![Updates of Key Studies Differ on Relative Benefit of Nab-Paclitaxel in Breast Cancer - The ASCO Post Updates of Key Studies Differ on Relative Benefit of Nab-Paclitaxel in Breast Cancer - The ASCO Post](https://ascopost.com/media/14007219/35_table.jpg)
Updates of Key Studies Differ on Relative Benefit of Nab-Paclitaxel in Breast Cancer - The ASCO Post
![Nab-Paclitaxel: A Novel Formulation of Taxane for Treatment of Breast Cancer - Prakash Vishnu, Vivek Roy, 2010 Nab-Paclitaxel: A Novel Formulation of Taxane for Treatment of Breast Cancer - Prakash Vishnu, Vivek Roy, 2010](https://journals.sagepub.com/cms/10.2217/WHE.10.42/asset/images/large/10.2217_whe.10.42-fig3.jpeg)
Nab-Paclitaxel: A Novel Formulation of Taxane for Treatment of Breast Cancer - Prakash Vishnu, Vivek Roy, 2010
![Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients | Advances in Therapy Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-019-01058-6/MediaObjects/12325_2019_1058_Fig2_HTML.png)
Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients | Advances in Therapy
![Paclitaxel vs Abraxane (albumin-bound paclitaxel) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group Paclitaxel vs Abraxane (albumin-bound paclitaxel) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://i0.wp.com/pharmaceuticalintelligence.com/wp-content/uploads/2020/07/paclitaxel-vs-abraxane-albumin-bound-paclitaxel.png?resize=500%2C310&ssl=1)
Paclitaxel vs Abraxane (albumin-bound paclitaxel) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
![Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial - The Lancet Gastroenterology & Hepatology Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/2091737319/2076224900/gr1.gif)
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial - The Lancet Gastroenterology & Hepatology
![Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/e2916075-4a0f-4aac-8bbd-8817585876bd/gr1.gif)
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology
![Modified Nab-Paclitaxel/Gemcitabine in Pancreatic Cancer: Efficacious, Less Toxic, Less Costly - The ASCO Post Modified Nab-Paclitaxel/Gemcitabine in Pancreatic Cancer: Efficacious, Less Toxic, Less Costly - The ASCO Post](https://ascopost.com/media/2974/60204_chart.jpg)
Modified Nab-Paclitaxel/Gemcitabine in Pancreatic Cancer: Efficacious, Less Toxic, Less Costly - The ASCO Post
![Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives - ScienceDirect Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737216300834-gr1.jpg)
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives - ScienceDirect
![Comparison of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)... | Download Scientific Diagram Comparison of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)... | Download Scientific Diagram](https://www.researchgate.net/publication/358509275/figure/tbl1/AS:1128923756789760@1646167806020/Comparison-of-nanoparticle-albumin-bound-paclitaxel-nab-paclitaxel-with-solvent-based.png)